Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease

PLoS One. 2017 Sep 21;12(9):e0184580. doi: 10.1371/journal.pone.0184580. eCollection 2017.

Abstract

Hereditary Huntington's disease (HD) is associated with progressive motor, cognitive and psychiatric symptoms. A primary consequence of the HD mutation is the preferential loss of medium spiny projection cells with relative sparing of local interneurons in the striatum. In addition, among GABAergic striatal projection cells, indirect pathway cells expressing D2 dopamine receptors are lost earlier than direct pathway cells expressing D1 receptors. To test in vivo the functional integrity of direct and indirect pathways as well as interneurons in the striatum of male R6/1 transgenic mice, we assessed their c-Fos expression levels induced by a striatal-dependent cognitive task and compared them with age-matched wild-type littermates. We found a significant increase of c-Fos+ nuclei in the dorsomedial striatum, and this only at 2 months, when our HD mouse model is still pre-motor symptomatic, the increase disappearing with symptom manifestation. Contrary to our expectation, the indirect pathway projection neurons did not undergo any severer changes of c-Fos expression regardless of age in R6/1 mice. We also found a decreased activation of interneurons that express parvalbumin in the dorsomedial striatum at both presymptomatic and symptomatic ages. Finally, analysis of c-Fos expression in extended brain regions involved in the cognitive learning used in our study, demonstrates, throughout ages studied, changes in the functional connectivity between regions in the transgenic mice. Further analysis of the cellular and molecular changes underlying the transient striatal hyperactivity in the HD mice may help to understand the mechanisms involved in the disease onset.

MeSH terms

  • Animals
  • Conditioning, Operant / physiology*
  • Corpus Striatum / metabolism*
  • Corpus Striatum / pathology
  • Disease Models, Animal
  • Disease Progression
  • Huntington Disease / metabolism*
  • Huntington Disease / pathology
  • Male
  • Mice, Transgenic
  • Motor Activity / physiology
  • Neural Pathways / metabolism
  • Neural Pathways / pathology
  • Neurons / metabolism*
  • Neurons / pathology
  • Prodromal Symptoms
  • Proto-Oncogene Proteins c-fos / metabolism
  • Random Allocation
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / metabolism
  • Seizures / metabolism

Substances

  • DRD2 protein, rat
  • Proto-Oncogene Proteins c-fos
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2

Grants and funding

Our work was funded by the University of Bordeaux, France (to MC) and the Hereditary Disease Foundation, USA (to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.